This is a Validated Antibody Database (VAD) review about mouse mSiglec E, based on 3 published articles (read how Labome selects the articles), using mSiglec E antibody in all methods. It is aimed to help Labome visitors find the most suited mSiglec E antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
mSiglec E synonym: Cd170; Siglec12; Siglec5; Siglec9; Siglecl1; mSiglec-E

Knockout validation
BioLegend
rat monoclonal (M1304A01)
  • immunohistochemistry knockout validation; mouse; 1:100; fig 2c
BioLegend mSiglec E antibody (BioLegend, 677102) was used in immunohistochemistry knockout validation on mouse samples at 1:100 (fig 2c). J Neuroinflammation (2022) ncbi
BioLegend
rat monoclonal (M1304A01)
  • immunohistochemistry knockout validation; mouse; 1:100; fig 2c
BioLegend mSiglec E antibody (BioLegend, 677102) was used in immunohistochemistry knockout validation on mouse samples at 1:100 (fig 2c). J Neuroinflammation (2022) ncbi
rat monoclonal (M1304A01)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 3f
  • flow cytometry; mouse; fig 3e
BioLegend mSiglec E antibody (BioLegend, 677102) was used in immunohistochemistry - frozen section on mouse samples (fig 3f) and in flow cytometry on mouse samples (fig 3e). EMBO J (2017) ncbi
R&D Systems
domestic goat polyclonal
  • western blot; mouse; loading ...; fig 4d
R&D Systems mSiglec E antibody (R&D, AF5806) was used in western blot on mouse samples (fig 4d). J Biomed Sci (2021) ncbi
Articles Reviewed
  1. Li L, Chen Y, Sluter M, Hou R, Hao J, Wu Y, et al. Ablation of Siglec-E augments brain inflammation and ischemic injury. J Neuroinflammation. 2022;19:191 pubmed publisher
  2. Hsu Y, Hsu F, Chiang M, Tsai D, Li F, Angata T, et al. Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation. J Biomed Sci. 2021;28:5 pubmed publisher
  3. Schwarz F, Landig C, Siddiqui S, Secundino I, Olson J, Varki N, et al. Paired Siglec receptors generate opposite inflammatory responses to a human-specific pathogen. EMBO J. 2017;36:751-760 pubmed publisher